Showing 1 - 20 results of 22 for search 'Iwata N', query time: 0.07s
Refine Results
-
1
-
2
The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis by Kishi T, Matsunaga S, Iwata N
Published 2017-07-01
Article -
3
-
4
Memantine for the treatment of frontotemporal dementia: a meta-analysis by Kishi T, Matsunaga S, Iwata N
Published 2015-11-01
Article -
5
-
6
-
7
Nonlocal properties of ponderomotive force in strongly nonuniform high intensity laser fields by Iwata N., Kishimoto Y., Imadera K.
Published 2013-11-01
Article -
8
-
9
-
10
Early prediction of blonanserin response in Japanese patients with schizophrenia by Kishi T, Matsuda Y, Fujita K, Iwata N
Published 2014-09-01
Article -
11
-
12
-
13
Comparative clinical profile of mirtazapine and duloxetine in practical clinical settings in Japan: a 4-week open-label, parallel-group study of major depressive disorder by Nagao K, Kishi T, Moriwaki M, Fujita K, Hirano S, Yamanouchi Y, Funahashi T, Iwata N
Published 2013-06-01
Article -
14
Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study by Okamoto N, Watanabe K, Ngyuyen LH, Ikenouchi A, Kishi T, Iwata N, Kakeda S, Korogi Y, Yoshimura R
Published 2020-10-01
Article -
15
Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and... by Igeta H, Watanabe Y, Morikawa R, Ikeda M, Otsuka I, Hoya S, Koizumi M, Egawa J, Hishimoto A, Iwata N, Someya T
Published 2019-08-01
Article -
16
-
17
Genetic effects on white matter integrity in drug-naive patients with major depressive disorder: a diffusion tensor imaging study of 17 genetic loci associated with depressive symp... by Kakeda S, Watanabe K, Katsuki A, Sugimoto K, Ueda I, Igata N, Kishi T, Iwata N, Abe O, Yoshimura R, Korogi Y
Published 2019-01-01
Article -
18
Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials by Kishi T, Oya K, Matsui Y, Nomura I, Sakuma K, Okuya M, Matsuda Y, Fujita K, Funahashi T, Yoshimura R, Iwata N
Published 2018-10-01
Article -
19
Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial by Kishi T, Matsuda Y, Matsunaga S, Moriwaki M, Otake Y, Akamatsu K, Okochi T, Hirano S, Funahashi T, Okuda M, Tabuse H, Fujita K, Iwata N
Published 2017-01-01
Article -
20